Landec Corporation Inventory Turnover

Inventory Turnover of LNDC for past 10 years: annual, quarterly and twelve month trailing (TTM) including Inventory Turnover growth rates and interactive chart.

Highlights and Quick Summary

  • Annual Inventory Turnover for 2020 was 10.59 (a -23.9% decrease from previous year)
  • Annual Inventory Turnover for 2019 was 13.92 (a -22.35% decrease from previous year)
  • Annual Inventory Turnover for 2018 was 17.92 (a 13.56% increase from previous year)
  • Twelve month Inventory Turnover ending February 27, 2021 was 7.39 (a -11.37% decrease compared to previous quarter)
  • Twelve month trailing Inventory Turnover decreased by -13.07% year-over-year
Trailing Inventory Turnover for the last four month:
27 Feb '21 29 Nov '20 30 Aug '20 30 May '20
7.39 8.34 8.43 8.51
Visit for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Inventory Turnover of Landec Corporation

Most recent Inventory Turnoverof LNDC including historical data for past 10 years.

Interactive Chart of Inventory Turnover of Landec Corporation

Landec Corporation Inventory Turnover for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 10.59
2019 13.92
2018 17.92
2017 15.78
2016 18.79
2015 19.04
2014 16.96
2013 16.43
2012 12.59
2011 12.69
2010 18.64

Business Profile of Landec Corporation

Sector: Consumer Defensive
Industry: Packaged Foods
Landec Corporation, together with its subsidiaries, designs, develops, manufactures, and sells differentiated health and wellness products for food and biomaterials markets. It operates through Curation Foods and Lifecore segments. The Curation Foods segment engages in processing, marketing, and selling of vegetable-based salads, and fresh-cut and whole vegetable products primarily under the Eat Smart brand, O branded olive oils and wine vinegars, and Yucatan and Cabo Fresh guacamole and avocado food products, as well as various private labels. It serves retail grocery chains, club stores, and food service operators. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, including technology transfer, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic, orthopedic, and other markets. It sells its products directly to partners in the medical device and pharmaceutical markets. The company was founded in 1986 and is headquartered in Santa Clara, California.